Background:
The liver is an important organ in cardio-kidney-metabolic (CKM) disease because of its essential roles in glucose homeostasis, cholesterol synthesis, and drug metabolism. We evaluated whether baseline liver fibrosis risk, estimated using the Fibrosis-4 (FIB-4) index, influenced treatment responses to es...
R. Helseth, J. Green, J. McGill et al.· Circulation· 0 citations
Abstract Background The nomenclature change from non-alcoholic fatty liver disease to metabolic dysfunction-associated steatotic liver disease (MASLD) better encapsulates the associated metabolic milieu. While MASLD is associated with increased heart failure (HF) risk, characteristics and outcomes of MASLD in patients...
N. Chew, Chandramouli Chanchal, W. Tay et al.· Open Heart· 0 citations
AIMS
To investigate the association between serial high-sensitivity cardiac troponin-T (hs-TnT) concentrations and subsequent heart failure in individuals presenting with suspected acute coronary syndrome (ACS).
METHODS AND RESULTS
Utilizing Danish nationwide registries, we identified individuals without known heart...
Philip Ahle Erichsen, Majid Afzal, Christina Byrne et al.· International Journal of Car...· 1 citation
BACKGROUND
Heart failure with improved ejection fraction (HFimpEF) is a rapidly growing clinical entity. There is little understanding of how sex relates to the epidemiology, predictors, and trajectory of HFimpEF.
OBJECTIVES
The authors aimed to describe sex-based differences in the epidemiology, guideline-directed m...
Yi-Lin Liang, Lochan M. Shah, R. Parikh et al.· JACC. Heart failure· 1 citation
Although lower than PREVENT, KFRE showed moderate discrimination for CV disease prediction, offering dual kidney and CV risk stratification with a single simple tool.
Simon Correa, V. Castro, I. Beldhuis et al.· Kidney360· 0 citations
BACKGROUND AND AIMS
N-terminal pro-B-type natriuretic peptide (NT-proBNP) is recommended to guide echocardiography referral in community-based patients with suspected heart failure (HF), but diagnostic performance is influenced by individual characteristics including age, ethnicity, kidney function, cardiac rhythm, and...
K. Docherty, B. Heywood, L. Anderson et al.· European Heart Journal· 0 citations
BACKGROUND
Patients with chronic kidney disease (CKD) and type 2 diabetes (T2D) face high but modifiable risks of incident heart failure (HF). We aimed to ascertain whether the HFpEF-ABA score, a simple 3-variable tool to facilitate timely diagnosis of HFpEF, is associated with adverse cardiovascular (CV) outcomes in p...
R. Inciardi, J. Ostrominski, B. Claggett et al.· Journal of Cardiac Failure· 0 citations
Heart failure (HF) remains a major cause of morbidity, mortality, and increased healthcare costs worldwide, and is recognized as the result of progressive cardiovascular-kidney-metabolic (CKM) syndrome. Obesity, type 2 diabetes, chronic kidney disease, hypertension, and atherosclerotic cardiovascular disease frequently...
R. Inciardi, A. Abdin, M. Abdelhamid et al.· European Journal of Heart Fa...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.